Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2014 /
High levels of mutated p53 indicate metastatic phenotype

5th - 9th Apr 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 05.05.14
Views: 2054

Dr Guillermina Lozano - The University of Texas MD Anderson Cancer Center, Houston, USA

Dr Lozano talks to ecancertv at the AACR conference about her work work with the mutated p53 gene.

Her study found that high levels of mutated p53 were at high risk of developing metastases.

By checking for levels of p53, doctors can be better informed of the best chemotherapy treatment options.

Though they have not yet found a way to eradicate this gene, the findings offer a meaningful contribution to personalised medicine. 



Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence